PTPA and chronic myelogenous leukemia, BCR-ABL1 positive: Remarkably, drugs such as forskolin, 1,9-dideoxy-forskolinand FTY720, which lead to PP2A activation, effectively antagonize leukemogenesis in both in vitro and in vivo models of CML and Ph+ B-ALL(see the introduction).